Net Cash Provided by (Used in) Operating Activities |
-13K |
USD |
+18.7% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
13.1K |
USD |
-18.2% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
1B |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
4.5M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
99 |
USD |
+254% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
5 |
USD |
-66.7% |
Q3 2024 |
Q3 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2024 |
Q1 2024 |
Depreciation |
0 |
USD |
-100% |
Q1 2022 |
Q1 2022 |
Preferred Stock, Shares Issued |
1.94M |
shares |
|
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
10M |
shares |
|
Q3 2024 |
Q3 2024 |
Additional Paid in Capital |
534K |
USD |
0% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Outstanding |
1.94M |
shares |
|
Q3 2024 |
Q3 2024 |
Depreciation, Depletion and Amortization |
0 |
USD |
-100% |
Q4 2022 |
FY 2022 |
Deferred Tax Assets, Net of Valuation Allowance |
209K |
USD |
+4.5% |
Q3 2024 |
Q3 2024 |
Interest Expense |
8.12K |
USD |
+14.1% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2024 |
Q3 2024 |